Programme Thesis
The Commonwealth Startup Fellowship funds early-stage entrepreneurs from low/middle-income Commonwealth countries to scale innovative startups through a hybrid capacity-building programme, culminating in a two-week bootcamp in Accra and potential London capstone events. It exists to build entrepreneurial capacity, foster global networking, and drive economic growth and job creation in home countries.
Selection Criteria
- Graduate-level individual
- Citizen of (or refugee status in) a low/middle-income Commonwealth country
- Permanent residence in an eligible country
- Fluent written and spoken English
- Not received a Commonwealth Professional Fellowship in the last 5 years
- Available for full fellowship schedule (including Accra bootcamp 14–30 Nov 2025)
- Innovation in product, service, or market strategy
- Active business development for at least 6 months
- Working MVP, service, or prototype
- Proof of customer traction (early sales, pre-sales, signed contracts, or similar evidence)
- Commitment to scaling impact and contributing to home-country economic growth
Past Winners / Cohort Profiles
The programme is relatively new (Cohort Two in 2025); past winners from Cohort One likely include early-stage founders from sectors like agritech, healthtech, fintech, and clean energy, with demonstrated traction and a clear social impact angle. Named examples are not available on the page, but typical archetypes are founders with a working prototype, some customer validation, and a scalable business model addressing a pressing local or global challenge.
Ideal Candidate Fingerprint
A graduate-level entrepreneur from a low/middle-income Commonwealth country with a working MVP, clear customer traction (e.g., early sales or signed contracts), and a scalable innovation that directly addresses a pressing challenge in their home country or globally. The ideal applicant shows strong commitment to building a sustainable business that creates jobs and economic growth, and is available for the full hybrid programme including the Accra bootcamp.
Recommended Framing
Eniola Olutogun should position the venture as an AI-driven drug resistance prediction platform tackling antimicrobial resistance (AMR) and oncology—global health crises that disproportionately affect low/middle-income Commonwealth countries like Nigeria. Emphasise her unique pharmacist-to-ML engineer journey, the venture's ability to predict mutations without crystal structures (democratising drug discovery), and early traction (AUROC 0.634, 100% mutation coverage) as proof of innovation and customer traction. Highlight how the platform can reduce drug development costs and improve treatment outcomes in resource-limited settings, directly aligning with the fellowship's goal of scalable impact and economic growth in home countries.
Watch Out
The venture is not yet incorporated, which may weaken proof of 'active business development for at least 6 months' and customer traction. Eniola must clearly document any pre-sales, letters of intent, or pilot discussions (e.g., with Servier) to satisfy the traction requirement. Additionally, the fellowship requires permanent residence in an eligible Commonwealth country; if Eniola is currently based outside such a country (e.g., in France), this could be a disqualifier unless she maintains Nigerian residency.